Atlas Arteria (ALX) AGM 2026 summary

Opening remarks and agenda

• Meetings held as hybrid events for both Atlas Arteria Limited (ATLAX) and Atlas Arteria International Limited (ATLIX), with security holders attending in person and online.

• Chairs of both entities, directors up for re-election, and the CEO addressed attendees; voting on all resolutions conducted by poll.

• Housekeeping, voting, and Q&A procedures explained for both in-person and online participants.

Financial performance review

• 2025 marked a positive year with proportional EBITDA up 9.3% and toll revenue growth across all businesses.

• Distributions of AUD 0.40 per security delivered, in line with guidance, despite the impact of the French government's temporary supplementary tax (TST).

• 2026 distribution guidance maintained at AUD 0.40 per security, subject to business performance and external factors.

• First quarter of 2026 saw limited macroeconomic impact, with toll revenue up 0.1% (1.6% including FX), and continued strong traffic growth at Dulles Greenway.

Board and executive committee updates

• Several directors stood for re-election, with unanimous board support for all candidates except where conflicted.

• Chair succession process underway, with Debbie Goodin confirming this is her last re-election and emphasizing the importance of an orderly transition.

• IFM nominee directors actively involved in strategy and governance, with clear separation between their board roles and IFM HQ as a shareholder.